Gilbert S Omenn - Net Worth and Insider Trading
Gilbert S Omenn Net Worth
The estimated net worth of Gilbert S Omenn is at least $60 Million dollars as of 2024-09-20. Gilbert S Omenn is the Director of Amgen Inc and owns about 176,783 shares of Amgen Inc (AMGN) stock worth over $59 Million. Gilbert S Omenn is the Director of Galectin Therapeutics Inc and owns about 66,769 shares of Galectin Therapeutics Inc (GALT) stock worth over $189,624. Gilbert S Omenn is also the Director of Esperion Therapeutics Inc and owns about 11,000 shares of Esperion Therapeutics Inc (ESPR) stock worth over $19,085. Besides these, Gilbert S Omenn also holds Amesite Inc (AMST) . Details can be seen in Gilbert S Omenn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gilbert S Omenn has not made any transactions after 2021-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gilbert S Omenn
Gilbert S Omenn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gilbert S Omenn owns 7 companies in total, including Amesite Inc (AMST) , Galectin Therapeutics Inc (GALT) , and Esperion Therapeutics Inc (ESPR) among others .
Click here to see the complete history of Gilbert S Omenn’s form 4 insider trades.
Insider Ownership Summary of Gilbert S Omenn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMST | Amesite Inc | 2023-09-29 | director |
| GALT | Galectin Therapeutics Inc | 2020-01-09 | director |
| ESPR | Esperion Therapeutics Inc | 2017-03-21 | director |
 | | 2012-11-26 | director |
| | 2007-07-03 | director |
| | 2021-02-04 | director |
| | 2021-02-04 | director |
Gilbert S Omenn Latest Holdings Summary
Gilbert S Omenn currently owns a total of 4 stocks. Among these stocks, Gilbert S Omenn owns 176,783 shares of Amgen Inc (AMGN) as of November 26, 2012, with a value of $59 Million and a weighting of 99.62%. Gilbert S Omenn owns 66,769 shares of Galectin Therapeutics Inc (GALT) as of May 31, 2019, with a value of $189,624 and a weighting of 0.32%. Gilbert S Omenn also owns 11,000 shares of Esperion Therapeutics Inc (ESPR) as of March 21, 2017, with a value of $19,085 and a weighting of 0.03%. The other 1 stocks Amesite Inc (AMST) have a combined weighting of 0.03% among all his current holdings.
Latest Holdings of Gilbert S Omenn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | 2012-11-26 | 176,783 | 335.95 | 59,390,249 |
| GALT | Galectin Therapeutics Inc | 2019-05-31 | 66,769 | 2.84 | 189,624 |
| ESPR | Esperion Therapeutics Inc | 2017-03-21 | 11,000 | 1.74 | 19,085 |
| AMST | Amesite Inc | 2021-12-14 | 6,472 | 2.45 | 15,867 |
Holding Weightings of Gilbert S Omenn
Gilbert S Omenn Form 4 Trading Tracker
According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 26,000 shares on November 26, 2012, which brought Gilbert S Omenn around $2 Million.
According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 18,578 shares on May 31, 2019, which cost Gilbert S Omenn around $79,514.
According to the SEC Form 4 filings, Gilbert S Omenn has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 1,000 shares on March 21, 2017, which cost Gilbert S Omenn around $42,260.
More details on Gilbert S Omenn's insider transactions can be found in the Insider Trading History of Gilbert S Omenn table.Insider Trading History of Gilbert S Omenn
- 1
Gilbert S Omenn Trading Performance
GuruFocus tracks the stock performance after each of Gilbert S Omenn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gilbert S Omenn is -11.99%. GuruFocus also compares Gilbert S Omenn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gilbert S Omenn within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gilbert S Omenn's insider trading performs compared to the benchmark.
Performance of Gilbert S Omenn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.46 | | | | | |
| Relative Return to S&P 500(%) | -3.97 | | | | | |
Gilbert S Omenn Ownership Network
Gilbert S Omenn Owned Company Details
What does Amesite Inc do?
Who are the key executives at Amesite Inc?
Gilbert S Omenn is the director of Amesite Inc. Other key executives at Amesite Inc include director & Chief Executive Officer Ann Marie Sastry , Chief Financial Officer Sherrie Farrell , and Chief Financial Officer Mark Corrao .
Amesite Inc (AMST) Insider Trades Summary
Over the past 18 months, Gilbert S Omenn made no insider transaction in Amesite Inc (AMST). Other recent insider transactions involving Amesite Inc (AMST) include a net purchase of 10,000 shares made by Ann Marie Sastry ,
In summary, during the past 3 months, insiders sold 0 shares of Amesite Inc (AMST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amesite Inc (AMST) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.
Amesite Inc (AMST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amesite Inc Insider Transactions
Gilbert S Omenn Mailing Address
Above is the net worth, insider trading, and ownership report for Gilbert S Omenn. You might contact Gilbert S Omenn via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
